Navigation Links
Maroon 5 Lead Singer Adam Levine Raises Awareness of Attention-Deficit/Hyperactivity Disorder in Young Adults and Adults With "Own It"
Date:6/20/2011

ents, according to the Centers for Disease Control and Prevention (CDC).  The disorder is also estimated to affect 4.4 percent of US adults aged 18 to 44 based on results from the National Comorbidity Survey Replication.  When this percentage is extrapolated to the full US population aged 18 and over, approximately 10 million adults are believed to have ADHD.

The specific etiology of ADHD is unknown, and there is no single diagnostic test for this disorder. Adequate diagnosis requires the use of medical and special psychological, educational, and social resources, utilizing diagnostic criteria specified in the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision (DSM-IV-TR®) or International Classification of Diseases, 10th revision (ICD-10).

Although there is no cure for ADHD, there are accepted treatments that have been demonstrated to improve symptoms.  Standard treatments include educational approaches, psychological therapies, which may include behavioral modification, and/or medication.  For further information please contact:MediaMatthew Cabreymcabrey@shire.com

+1 484 595 8248Cori Blair (Porter Novelli for Shire)cori.blair@porternovelli.com

+1 212 601 8248Evelyn Green (ADDA)info@add.org

+1 800 939 1019Susan Buningh (CHADD) Susan_Buningh@chadd.org

+1 301 306 7070 x102SHIRE PLCShire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician.  Shire focuses its business on attention deficit hyperactivity disorder (ADHD), human genetic therapies (HGT) and gastrointestinal (GI) diseases as well as opportunities in other therapeutic areas to the exten
'/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Interleukin Genetics and Geisinger to Collaborate on Genetic Tests to Predict Weight Loss Success
2. World-Renowned Singer Youssou NDour Launches NightWatch Program
3. Segal McCambridge Singer & Mahoney, Ltd. and Greenberg Traurig, LLP Obtain Three Defense Verdicts for I-Flow in Oregon Infusion Pump Cases
4. Cepheid Announces Nomination of Geisinger Health System CEO and Renowned Oncology Researcher to Board of Directors
5. Globus Medical Raises $110 Million in Series E Financing Round
6. EntreMed Raises $20 Million to Support Clinical Development Program
7. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
8. Romark Laboratories Raises $18 Million in Institutional Financing
9. Light Sciences Oncology Raises $40.1 Million in Series C Financing
10. Celator Pharmaceuticals Raises Series C Financing in Excess of $22.5 Million
11. ESBATech Raises Additional CHF 23M (USD 22M), Extending Series B Venture Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... STAMFORD, Conn. , Aug. 31, 2015 /PRNewswire/ ... Ltd., and Purdue Pharma L.P. announced today that they ... development and commercialization of Eisai,s clinical candidate lemborexant (development ... III clinical development for the treatment of insomnia. ... and Purdue Pharma will share the costs of lemborexant ...
(Date:8/31/2015)... 2015 Bionomics Limited (ASX:BNO, ADR:BMICY), a biopharmaceutical ... therapeutics for the treatment of diseases of the central ... BNC101 IND submission has passed review by the US ... a Phase 1 clinical trial in patients with metastatic ... prior to 31 December 2015. Bionomics, CEO ...
(Date:8/31/2015)... , Aug. 31, 2015 Research ... addition of the "Prescription Pain Drugs - ... Marijuana - Global Markets, Competitors and Opportunities: 2015 ... their offering. Pain is defined ... with actual or potential tissue damage. At some ...
Breaking Medicine Technology:Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 2Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 3Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 4Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 5Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 2Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 3Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 4Prescription Pain Drugs Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts 2Prescription Pain Drugs Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts 3
... DIEGO, Jan. 7, 2011 ADVENTRX Pharmaceuticals, Inc. (NYSE ... has entered into definitive agreements to sell 8,184,556 units ... certain healthcare-focused investors, and other institutional investors for a ... to ADVENTRX of approximately $22.5 million.  Each unit consists ...
... Jan. 7, 2011 WaferGen Biosystems, Inc. (OTC Bulletin ... state-of-the-art genomic analysis systems, today announced that it will ... Annual OneMedForum Business Development and Investment Conference for emerging ... JP Morgan Healthcare Conference in San Francisco, January 11-13, ...
Cached Medicine Technology:ADVENTRX Pharmaceuticals Announces Capital Raise of $22.5 Million 2ADVENTRX Pharmaceuticals Announces Capital Raise of $22.5 Million 3WaferGen to Present at OneMedForum San Francisco 2011 2
(Date:9/1/2015)... York, NY (PRWEB) , ... September 01, 2015 ... ... that, to date, more than 1,500 investor-families have received permanent green cards (I-829 ... EB-5 projects. , The I-829 petition is the final step of the EB-5 ...
(Date:9/1/2015)... , ... September 01, 2015 , ... ... popular VitaSkin™ collection of products, the VitaSkin™ Exfoliating Peels. This revolutionary collection of ... pillars: Firm, Bright, Calm, and Clear. , Formulated with alpha hydroxy acids ...
(Date:9/1/2015)... ... 2015 , ... The integration of Practice Perfect and FOTO ... to FOTO enabling cost and time savings, reducing errors and omissions, and eliminating ... Practice Perfect, stated "FOTO is a natural extension of Practice Perfect, assisting ...
(Date:9/1/2015)... ... September 01, 2015 , ... A new episode of “Voices In America”, ... look at the topic of arthritis. There are over 100 different types of arthritis. ... types and statistics in an effort to shed light on this important topic. , ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... of professional hair salons. This highly anticipated partnership between Curly Hair Solutions™ and ... Styling Collection. Founder Jonathan Torch and the Curly Hair Solutions™ team could not ...
Breaking Medicine News(10 mins):Health News:CanAm Enterprises Reaches Another Milestone with More Than 1,500 I-829 Petition Approvals 2Health News:Éminence Organic Skin Care Introduces Results-Oriented Exfoliating Peels for Every Skin Type 2Health News:Éminence Organic Skin Care Introduces Results-Oriented Exfoliating Peels for Every Skin Type 3Health News:FOTO Announces New Integration Partnership with Practice Perfect 2Health News:Curly Hair Solutions™ Partners With Trade Secrets 2
... and mother of special needs child, Chelle Brewer,s, story of triumph over ... ... worldwide, PITTSBURGH, Jan. 23 27-year-old Chelle Brewer,s soldier,husband is nearing ... for injuries sustained in a military training accident. Her,three-year old daughter was ...
... research pinpoints reward center, which can go awry , , ... that a specific part of the brain handles what ... The research could lead scientists closer to more effective ... understanding of a brain region is helpful because it ...
... on the use of stem cells for cardiac repair ... of the Heart Failure Association of the European Society ... Findings in experiments conducted with rodent engineered heart tissue ... stem cells for use in cardiac repair. Over one ...
... 23 University students in America,are turning to ... focus, stay up late, and cram for finals. ... Disorder,(ADHD), can improve concentration but may also pose ... a lot in the past twenty years. The ...
... 2008, Gestiva(TM), is Designated as an Orphan Drug by ... ... LOUIS, Jan. 22 KV Pharmaceutical Company,(NYSE: KVa/KVb), a ... markets technology-differentiated,branded and generic/non-branded prescription pharmaceutical products,announced today that ...
... Today,s USA Today,features a major story in the Life ... telling the stories of more than 40 organ donors ... was a 7-year-old boy killed,during a family vacation in ... of seven Italians and triggering worldwide awareness of the ...
Cached Medicine News:Health News:'Military Spouse of the Year 2008' Announced 2Health News:Specific Brain Region Governs Problem-Solving Skills 2Health News:Specific Brain Region Governs Problem-Solving Skills 3Health News:Prescription 'Mind Meds' Pose Dangerous Threat to College Students 2Health News:KV Pharmaceutical Company Announces Acquisition of Rights to Gestiva(TM) 2Health News:KV Pharmaceutical Company Announces Acquisition of Rights to Gestiva(TM) 3Health News:KV Pharmaceutical Company Announces Acquisition of Rights to Gestiva(TM) 4Health News:KV Pharmaceutical Company Announces Acquisition of Rights to Gestiva(TM) 5
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: